natgillin/translations-raw huggingface dataset:
Artikel 1, stk. 2, anvendes for licenser udstedt fra dens ikrafttrædelsesdato.
Article 1(2) shall apply on licences issued as from its entry into force.
Rådets forordning (EF) nr. 129/2007
Council Regulation (EC) No 129/2007
om sikring af toldfri behandling af specificerede aktive farmaceutiske ingredienser på WHO's liste over internationale ikke-navnebeskyttede navne (INN) og af specificerede varer, der anvendes til fremstilling af farmaceutiske færdigvarer, og om ændring af bilag I til forordning (EØF) nr. 2658/87
providing for duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceuticals and amending Annex I to Regulation (EEC) No 2658/87
Under forhandlingerne i Uruguay-runden vedtog Fællesskabet og en række lande, at der bør indrømmes toldfri behandling for farmaceutiske varer henhørende under kapitel 30 i det harmoniserede system (HS) og HS-position 2936, 2937, 2939 og 2941 og for nærmere angivne aktive farmaceutiske ingredienser med internationale ikke-navnebeskyttede navne (INN) fra Verdenssundhedsorganisationen (WHO) samt for nærmere angivne salte, estere og hydrater af sådanne varer og desuden for nærmere angivne varer, der anvendes til produktion og fremstilling af farmaceutiske færdigvarer.
In the course of the Uruguay Round negotiations, the Community and a number of countries agreed that duty-free treatment should be granted to pharmaceutical products falling within the Harmonised System (HS) Chapter 30 and HS headings 2936, 2937, 2939 and 2941 as well as to designated pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organisation, specified salts, esters or hydrates of such INNs, and designated intermediates used for the production and manufacture of finished products.
Resultaterne af drøftelserne som gengivet i referatet blev indarbejdet i deltagernes toldlister, der er bilagt Marrakesh-protokollen til GATT 1994.
The results of the discussions, as set out in the record of discussions, were incorporated into the tariff schedules of the participants, annexed to the Marrakesh Protocol to the GATT 1994.
Deltagerne konkluderede, at repræsentanterne for de medlemmer af Verdenshandelsorganisationen (WTO), der deltog i drøftelserne, skal mødes inden for rammerne af WTO's Råd for Handel med Varer, sædvanligvis mindst én gang hvert tredje år, for at revidere varedækningen med henblik på ved konsensus at tilføje yderligere farmaceutiske varer, der ikke længere skal belægges med told.
Participants concluded that representatives of the WTO members, party to the record of discussions, would meet under the auspices of the WTO Council for Trade in Goods, normally at least once every three years to review the product coverage with a view to including, by consensus, additional pharmaceutical products for tariff elimination.
I løbet af tre sådanne revisioner blev det konkluderet, at der bør indrømmes behandling med toldfritagelse af yderligere et bestemt antal INN og mellemprodukter, der bruges til produktion og fremstilling af farmaceutiske færdigvarer, at visse af disse mellemstoffer bør overføres til listen over INN, og at listen over nærmere bestemte præfikser og suffikser for salte, estere eller hydrater af INN bør udvides.
In the course of three such reviews it was concluded that a certain number of additional INNs and intermediates used for production and manufacture of finished pharmaceuticals should be granted duty-free treatment, that certain of these intermediates should be transferred to the list of INNs, and that the list of specified prefixes and suffixes for salts, esters or hydrates of INNs should be expanded.
Rådets forordning (EØF) nr. 2658/87 af 23. juli 1987 om told- og statistiknomenklaturen og den fælles toldtarif har indført den kombinerede nomenklatur og fastsat den fælles toldtarifs konventionelle toldsatser.
Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff established the Combined Nomenclature (CN) and set out the conventional duty rates of the Common Customs Tariff.
Forordning (EØF) nr. 2658/87 bør ændres i overensstemmelse hermed —
Regulation (EEC) No 2658/87 should therefore be amended accordingly,
Fra den 1. januar 2007 indrømmer Fællesskabet toldfritagelse for de i bilag I angivne INN.
As from 1 January 2007 the Community shall extend duty-free treatment to the INNs listed in Annex I.
Listen over præfikser og suffikser, som i forbindelse med INN beskriver de salte, estere eller hydrater af INN, som også er berettigede til behandling med toldfritagelse, under forudsætning af at disse kan tariferes under samme 6-cifrede HS-underpositioner som de tilsvarende INN, erstattes fra den 1. januar 2007 med listen i bilag II.
As from 1 January 2007 the list of prefixes and suffixes which, in combination with the INNs, describe the salts, esters or hydrates of INNs which are also eligible for duty-free treatment, on condition that they are classifiable in the same six-digit HS-subheading as the corresponding INN, shall be replaced by the list in Annex II.
Fra den 1. januar 2007 indrømmer Fællesskabet toldfritagelse for de mellemprodukter, der anvendes til produktion og fremstilling af de farmaceutiske varer, der er opført i bilag III.
As from 1 January 2007 the Community shall extend duty-free treatment to the intermediates used in the production and manufacture of pharmaceutical products listed in Annex III.
Fra den 1. januar 2007 indrømmes der ikke længere toldfritagelse for de i bilag IV angivne mellemprodukter.
As from 1 January 2007 the intermediates listed in Annex IV shall no longer benefit from duty-free treatment.
Bilag 3, 4 og 6 i afsnit II, del III, i bilag I til forordning (EØF) nr. 2658/87 (Liste over farmaceutiske stoffer, som opfylder betingelserne for behandling med toldfritagelse) ændres i overensstemmelse hermed.
Annexes 3, 4 and 6 of Section II of Part three of Annex I to Regulation (EEC) No 2658/87 (Lists of pharmaceutical substances which qualify for duty-free treatment) shall be amended accordingly.
Senest ændret ved forordning (EF) nr. 1930/2006 (EFT L 406 af 30.12.2006, s. 9).
Regulation as last amended by Regulation (EC) No 1930/2006 (OJ L 406, 30.12.2006, p. 9).
Liste over internationale ikke-navnebeskyttede navne (INN), der skal tilføjes på listen over de produkter, der er fritaget for told, og som er anført i bilag 3 til Kommissionens forordning (EF) nr. 1549/2006ID #
List of international non-proprietary names (INNs) to be added to the list of products receiving duty-free treatment included in Annex 3 to Commission Regulation (EC) No 1549/2006ID No
triplatintetranitrat
triplatin tetranitrate
technetium(99mTc)nitridocad
technetium (99mTc) nitridocade
technetium(99mTc)fanolsomab
technetium (99mTc) fanolesomab
yttrium(90Y)tacatuzumabtetraxetan(yttrium (90Y)tacatuzumab)
yttrium (90Y) tacatuzumab tetraxetan (yttrium (90Y) tacatuzumab)
gadocoletinsyre
gadocoletic acid
gadodenterat
gadodenterate
nebicapon
nebicapone
arundinsyre
arundic acid
tisocalcitat
tisocalcitate
gemcaben
gemcabene
trodusquemin
trodusquemine
edronocain
edronocaine
caloxetinsyre
caloxetic acid
cargluminsyre
carglumic acid
lacosamid (erlosamid)
lacosamide (erlosamide)
salcaprozinsyre
salcaprozic acid
salclobuzinsyre
salclobuzic acid
olanxidin
olanexidine
disufentonnitrat
disufenton sodium
canfosfamid
canfosfamide
lidadroninsyre
lidadronic acid
ascorbylgamolenat
ascorbyl gamolenate
fluoresceinlisicol
fluorescein lisicol
paclitaxelceribat
paclitaxel ceribate
fondaparinuxnatrium
fondaparinux sodium
idraparinuxnitrat
idraparinux sodium
dapiclermin
dapiclermine
mecaserminrinfabat
mecasermin rinfabate
crobenetin
crobenetine
ecalciden
ecalcidene
rivaniclin
rivanicline
ipravacain
ipravacaine
capravirin
capravirine
tebaniclin
tebanicline
ticaloprid
ticalopride
dabigatranetexilat
dabigatran etexilate
vareniclin
varenicline
isproniclin
ispronicline
dexmethylphenidat
dexmethylphenidate
caricotamid
caricotamide
tecastemizol
tecastemizole
tafenoquin
tafenoquine
gantacuriumchlorid
gantacurium chloride
sitamaquin
sitamaquine
albaconazol
albaconazole
eszopiclon
eszopiclone
eslicarbazepin
eslicarbazepine
licarbazepin
licarbazepine
bisoctrizol
bisoctrizole
apaziquon
apaziquone
licofelon
licofelone
icrocaptid
icrocaptide
altiniclin
altinicline
pactimib
pactimibe
fosfluconazol
fosfluconazole
mivotilat
mivotilate
ravuconazol
ravuconazole
acotiamid
acotiamide
alagebriumchlorid
alagebrium chloride
clofarabin
clofarabine
olmesartanmedoxomil (olmesartan)
olmesartan medoxomil (olmesartan)
posaconazol
posaconazole
fosfluridintidoxil
fosfluridine tidoxil
acolbifen
acolbifene
luliconazol
luliconazole
bulaquin
bulaquine
leconotid
leconotide
dianiclin
dianicline
embeconazol
embeconazole
tocladesin
tocladesine
ecallantid
ecallantide
arasertaconazol
arasertaconazole
insulinglulisin
insulin glulisine
parathyroidhormon
parathyroid hormone
zoticason
zoticasone
etiprednoldicloacetat
etiprednol dicloacetate
asoprisnilecamat
asoprisnil ecamate
anecortav
anecortave
morphinglucuronid
morphine glucuronide
midaxifyllin
midaxifylline
istradefyllin
istradefylline
naxifyllin
naxifylline
exatecanalideximer
exatecan alideximer
bimosiamos
bimosiamose
tigecyclin
tigecycline
tebipenempivoxil (tebipenem)
tebipenem pivoxil (tebipenem)
371918-51-3 (komponent A3), 371918-44-4 (komponent A4)
371918-51-3 (component A3), 371918-44-4 (component A4)
ceftobiprolmedocaril
ceftobiprole medocaril
cantuzumabmertansin
cantuzumab mertansine
drotrecogin alfa (aktiveret)
drotrecogin alfa (activated)
aviscumin
aviscumine
protaminsulfate
protamine sulfate
nasaruplasebeta
nasaruplase beta
paclitaxelpoliglumex
paclitaxel poliglumex
livaraparincalcium
livaraparin calcium
deligoparinnatrium
deligoparin sodium
Kommissionens forordning (EF) nr. 1549/2006 af 17. oktober 2006 om ændring af bilag I til Rådets forordning (EØF) nr. 2658/87 om told- og statistiknomenklaturen og den fælles toldtarif (EUT L 301 af 31.10.2006, s. 1).
Commission Regulation (EC) No 1549/2006 of 17 October 2006 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff (OJ L 301, 31.10.2006, p. 1).
Liste over præfikser og suffikser, som i forbindelse med de i bilag 3 til forordning (EF) nr. 1549/2006 nævnte INN beskriver salte, estere eller hydrater af INN; disse salte, estere og hydrater er fritaget for told, forudsat at de kan tariferes i samme 6-cifrede HS-underposition som det tilsvarende INN
List of prefixes and suffixes which, in combination with the INNs of Annex 3 to Regulation (EC) No 1549/2006, describe the salts, esters or hydrates of INNs; these salts, esters and hydrates are free of duty, on condition that they are classifiable in the same six-digit HS-subheading as the corresponding INN
Præfikser og suffikser kan kombineres (f.eks. hydrochloridphosphat).
Prefixes and suffixes can be combined (e.g. hydrochloride phosphate).
De kan have et multiplicerende præfiks som f.eks. bi, bis, di, hemi, hepta, hexa, mono, penta, sesqui, tetra, tri, tris… (f.eks. diacetat).
They can be preceded by a multiplying prefix such as bi, bis, di, hemi, hepta, hexa, mono, penta, sesqui, tetra, tri, tris… (e.g. diacetate).
Synonymer og systematiske navne kan også anvendes på samme måde.
Synonyms and systematic names can also be used, in the same way.
INN er WHO's International Nonproprietary Names for pharmaceutical substances (internationale ikke-navnebeskyttede navne på medicinske præparater)
INN means International Nonproprietary Names for pharmaceutical substances, World Health Organisation.
INNRG er International Nonproprietary Names (INN) for pharmaceutical substances, Names for radicals & groups (internationale ikke-navnebeskyttede navne (INN) på medicinske præparater, navne på radikaler og grupper), den omfattende liste fra 2004.
INNRG means International Nonproprietary Names (INN) for pharmaceutical substances, Names for radicals & groups, comprehensive list 2004.
INNCN er kemiske eller systematiske navne opført på listen over International Nonproprietary Names (INN) for pharmaceutical substances, Names for radicals & groups (internationale ikke-navnebeskyttede navne (INN) på medicinske præparater, navne på radikaler og grupper), den omfattende liste fra 2004.
INNCN means chemical or systematic name listed in International Nonproprietary Names (INN) for pharmaceutical substances, Names for radicals & groups, comprehensive list 2004.
Foretrukket præfiks eller suffiks
Preferred prefix or suffix
Systematisk navn (i tilfælde af forskel)
Systematic name when different
acefurat (INNRG)
acefurate (INNRG)
acetat (ester), furan-2-carboxylat (ester) (INNCN)
acetate (ester), furan-2-carboxylate (ester) (INNCN)
aceglumat (INNRG)
aceglumate (INNRG)
rac-hydrogen-N-acetylglutamat (INNCN)
rac-hydrogen N-acetylglutamate (INNCN)
aceponat (INNRG)
aceponate (INNRG)
acetat (ester), propanoat (ester) (INNCN)
acetate (ester), propanoate (ester) (INNCN)
acetat
acetate
1-phenylethan-1,1-diylbis(oxy)
1-phenylethane-1,1-diylbis(oxy)
aceturat (INNRG)
aceturate (INNRG)
N-acetylglycinat (INNCN)
N-acetylglycinate (INNCN)
acetylsalicylat
acetylsalicylate
2-(acetyloxy)benzoat
2-(acetyloxy)benzoate
acibutat (INNRG)
acibutate (INNRG)
acetat (ester), 2-methylpropanoat (ester) (INNCN)
acetate (ester), 2-methylpropanoate (ester) (INNCN)
acistrat (INNRG)
acistrate (INNRG)
acetat (ester), octadecanoat (ester) (INNCN)
acetate (ester), octadecanoate (ester) (INNCN)
adipat
adipate
hexandioat
hexanedioate
alfoscerat (INNRG)
alfoscerate (INNRG)
(2R)-2,3-dihydroxypropylhydrogenphosphat (INNCN)
(2R)-2,3-dihydroxypropyl hydrogen phosphate (INNCN)
poly([oxy(2-hydroxyethan-1,1-diyl)]oxy[1-(hydroxymethyl)ethan-1,2-diyl]) delvis O-etherificeret med carboxymethyl-grupper med visse amid-carboxy-grupper forbundet med tetrapeptidresten (glycylglycyl-L-phenylalanylglycyl) (INNCN)
poly([oxy(2-hydroxyethane-1,1-diyl)]oxy[1-(hydroxymethyl)ethane-1,2-diyl]) partly O-etherified with carboxymethyl groups with some carboxy groups amide linked to the tetrapeptide residue (glycylglycyl-L-phenylalanylglycyl) (INNCN)
N-allyl, bromid (salt)
N-allyl, bromide (salt)
allyliodid
allyloiodide
N-allyl, iodid (salt)
N-allyl, iodide (salt)
4-aminosalicylat
4-aminosalicylate
aminosalicylat
aminosalicylate
2-hydroxy-4-aminobenzoat
2-hydroxy-4-aminobenzoate
amsonat (INNRG)
amsonate (INNRG)
2,2'-ethen-1,2-diylbis(5-aminobenzen-1-sulfonat) (INNCN)
2,2'-ethene-1,2-diylbis (5-aminobenzene-1-sulfonate) (INNCN)
antipyrat
antipyrate
immunotoksin fremkommet ved sammenkobling af ricins A-kæde med MAB (INNCN)
ricin A chain-MAB immunotoxine (INNCN)
ascorbat
ascorbate
28B-L-asparaginsyre- (INNCN)
28B-L-aspartic acid- (INNCN)
aspartat
aspartate
barbiturat
barbiturate
2,4,6(1H,3H,5H)-pyrimidintrion
2,4,6(1H,3H,5H)-pyrimidinetrione
N,N'-dibenzylethylendiammonium
N,N'-dibenzylethylenediammonium
benzoacetat
benzoacetate
benzoat (INNRG)
benzoate (INNRG)
N-benzyl, bromid (salt)
N-benzyl, bromide (salt)
benzyliodid
benzyloiodide
N-benzyl, iodid (salt)
N-benzyl, iodide (salt)
besilat (INNRG)
besilate (INNRG)
besylat
besylate
benzensulfonat (INNCN), benzensulphonat
benzenesulfonate (INNCN), benzenesulphonate
borat
borate
buciclat (INNRG)
buciclate (INNRG)
trans-4-butylcyclohexancarboxylat (INNCN)
trans-4-butylcyclohexanecarboxylate (INNCN)
bunapsilat (INNRG)
bunapsilate (INNRG)
3,7-di-tert-butylnaphthalen-1,5-disulfonat (INNCN)
3,7-di-tert-butylnaphthalene-1,5-disulfonate (INNCN)
buteprat (INNRG)
buteprate (INNRG)
butyrat (ester), propionat (ester) (INNCN)
butyrate (ester), propionate (ester) (INNCN)
t-butyl, tertiær-butyl
t-butyl, tertiary butyl
tert-butylester
tert-butyl ester
t-butylester, tertiær-butylester
t-butyl ester, tertiary butyl ester
N-butyl, bromid (salt)
N-butyl, bromide (salt)
butyrat
butyrate
butylat
butylate
butanoat
butanoate
camphorat
camphorate
1,2,2-trimethyl-1,3-cyclopentandicarboxylat
1,2,2-trimethyl-1,3-cyclopentanedicarboxylate
camsilat (INNRG)
camsilate (INNRG)
camsylat, camphorsulfonat, camphorsulphonat, R-camphorsulfonat, R-camphorsulphonat, S-camphorsulfonat, S-camphorsulphonat, camphor-10-sulfonat, camphor-10-sulphonat
camsylate, camphorsulfonate, camphorsulphonate, R-camphorsulfonate, R-camphorsulphonate, S-camphorsulfonate, S-camphorsulphonate, camphor-10-sulfonate, camphor-10-sulphonate
(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methansulfonat (INNCN)
(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate (INNCN)
caproat (INNRG)
caproate (INNRG)
hexanoat (INNCN)
hexanoate (INNCN)
carbamat
carbamate
carbesilat (INNRG)
carbesilate (INNRG)
4-sulfobenzoat (INNCN)
4-sulfobenzoate (INNCN)
carbonat
carbonate
ciclotat (INNRG)
ciclotate (INNRG)
cyclotat
cyclotate
4-methylbicyclo[2.2.2]oct-2-en-1-carboxylat (INNCN)
4-methylbicyclo[2.2.2]oct-2-ene-1-carboxylate (INNCN)
cinnamat
cinnamate
3-phenylprop-2-enoat
3-phenylprop-2-enoate
cipionat (INNRG)
cipionate (INNRG)
cypionate, cyclopentanpropionat
cypionate, cyclopentanepropionate
3-cyclopentylpropanoat (INNCN), 3-cyclopentylpropionat
3-cyclopentylpropanoate (INNCN), 3-cyclopentylpropionate
citrat
citrate
2-hydroxypropan-1,2,3-tricarboxylat
2-hydroxypropane-1,2,3-tricarboxylate
2-(4-chlorphenoxy)-2-methylpropyl (INNCN)
2-(4-chlorophenoxy)-2-methylpropyl (INNCN)
closilat (INNRG)
closilate (INNRG)
closylat, p-chlorbenzensulfonat, p-chlorbenzensulphonat
closylate, p-chlorobenzenesulfonate, p-chlorobenzenesulphonate
4-chlorbenzen-1-sulfonat (INNCN), 4-chlorbenzensulfonat
4-chlorobenzene-1-sulfonate (INNCN), 4-chlorobenzenesulfonate
crobefat (INNRG)
crobefate (INNRG)
rac-3-[(3E)-4-methoxybenzyliden]-2-(4-methoxyphenyl)chroman- 6-ylphosphat(2-) (INNCN)
rac-3-[(3E)-4-methoxybenzylidene]-2-(4-methoxyphenyl)chroman- 6-yl phosphate(2-) (INNCN)
cromacat (INNRG)
cromacate (INNRG)
2-[(6-hydroxy-4-methyl-2-oxo-2H-chromen-7yl)oxy]acetat (INNCN)
2-[(6-hydroxy-4-methyl-2-oxo-2H-chromen-7yl)oxy]acetate (INNCN)
cromesilat (INNRG)
cromesilate (INNRG)
(6,7-dimethyl-2-oxobicyclo[2.2.1]heptan-4-yl)methansulfonat (INNCN)
(6,7-dihydroxy-2-oxo-2H-chromen-4-yl)methanesulfonate (INNCN)
cyclamat (INNRG)
cyclamate (INNRG)
N-cyclohexylsulfamat, N-cyclohexylsulphamat
N-cyclohexylsulfamate, N-cyclohexylsulphamate
cyclohexylsulfamat (INNCN)
cyclohexylsulfamate (INNCN)
cyclohexylamin
cyclohexylamine
cyclohexylpropionat
cyclohexylpropionate
cyclohexanpropionat
cyclohexanepropionate
cyclohexylpropanoat
cyclohexylpropanoate
daloxat (INNRG)
daloxate (INNRG)
L-alaninat (ester), (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (INNCN)
L-alaninate (ester), (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (INNCN)
daropat (INNRG)
daropate (INNRG)
dapropat
dapropate
3-(dimethylamino)propanoat (INNCN)
3-(dimethylamino)propanoate (INNCN)
decanoat
decanoate
des-1B-L-phenylalanin-insulin (INNCN)
des-1B-L-phenylalanine-insulin (INNCN)
dibudinat (INNRG)
dibudinate (INNRG)
2,6-di-tert-butylnaphthalen-1,5-disulfonat (INNCN)
2,6-di-tert-butylnaphthalene-1,5-disulfonate (INNCN)
dibunat (INNRG)
dibunate (INNRG)
2,6-di-tert-butylnaphthalen-1-sulfonate (INNCN)
2,6-di-tert-butylnaphthalene-1-sulfonate (INNCN)
dicibat (INNRG)
dicibate (INNRG)
dicyclohexylmethylcarbonat (INNCN)
dicyclohexylmethyl carbonate (INNCN)
dicyclohexylamin
dicyclohexylamine
N-L-methionyl-387-L-histidin-388-L-alanin-1-388-toxin (Corynbacterium diphtheriae stamme C7) (388→2')-protein (INNCN)
N-L-methionyl-387-L-histidine-388-L-alanine-1-388-toxin (Corynebacterium diphtheriae strain C7) (388→2')-protein (INNCN)
dihydroxybenzoat
dihydroxybenzoate
dinitrobenzoat
dinitrobenzoate
disulphid
disulphide
dofosfat (INNRG)
dofosfate (INNRG)
octadecylhydrogenphosphat (INNCN)
octadecyl hydrogen phosphate (INNCN)
ecamat (INNRG)
ecamate (INNRG)
N-ethylcarbamat (INNCN)
N-ethylcarbamate (INNCN)
edisilat (INNRG)
edisilate (INNRG)
edisylat, 1,2-ethandisulfonat, 1,2-ethandisulphonat
edisylate, 1,2-ethanedisulfonate, 1,2-ethanedisulphonate
ethan-1,2-disulfonat (INNCN)
ethane-1,2-disulfonate (INNCN)
embonat (INNRG)
embonate (INNRG)
pamoat, 4,4'-methylenbis(3-hydroxy-2-naphthoat)
pamoate, 4,4'-methylenebis(3-hydroxy-2-naphthoate)
4,4'-methylenbis(3-hydroxynaphthalen-2-carboxylat) (INNCN)
4,4'-methylenebis(3-hydroxynaphthalene-2-carboxylate) (INNCN)
enantat (INNRG)
enantate (INNRG)
enanthat
enanthate
heptanoat (INNCN)
heptanoate (INNCN)
enbutat (INNRG)
enbutate (INNRG)
acetat (ester), butanoat (ester) (INNCN)
acetate (ester), butanoate (ester) (INNCN)
tert-butylamin, t-butylamin, tert. butylamin
tert-butylamine, t-butylamine, tertiary butylamine
esilat (INNRG)
esilate (INNRG)
esylat, ethansulfonat, ethansulphonat
esylate, ethanesulfonate, ethanesulphonate
ethansulfonat (INNCN)
ethanesulfonate (INNCN)
estolat (INNRG)
estolate (INNRG)
propionatdodecylsulfat, propionatdodecylsulphat, propionatlaurylsulfat, propionatlaurylsulphat
propionate dodecyl sulfate, propionate dodecyl sulphate, propionate lauryl sulfate, propionate lauryl sulphate
propanoat (ester), dodecylsulfat (salt) (INNCN)
propanoate (ester), dodecyl sulfate (salt) (INNCN)
etabonat (INNRG)
etabonate (INNRG)
ethylcarbonat (INNCN)
ethyl carbonate (INNCN)
N-ethyl, bromid (salt)
N-ethyl, bromide (salt)
ethylenantat
ethylenantate
ethylheptanoat
ethylheptanoate
ethylhexanoat
ethylhexanoate
ethyliodid
ethyloiodide
N-ethyl, iodid (salt)
N-ethyl, iodide (salt)
ethylsuccinat
ethylsuccinate
etilsulfat (INNRG)
etilsulfate (INNRG)
ethylsulfat
ethylsulfate
ethylsulfat (INNCN)
ethyl sulfate (INNCN)
fendizoat (INNRG)
fendizoate (INNRG)
2-(6-hydroxybiphenyl-3-carbonyl)benzoat (INNCN)
2-(6-hydroxybiphenyl-3-carbonyl)benzoate (INNCN)
ferro jern-
ferrous
fluorsulfonat
fluorosulphonate
formiat
formate
fostedat (INNRG)
fostedate (INNRG)
tetradecylhydrogenphosphat (INNCN)
tetradecyl hydrogen phosphate (INNCN)
fumarat
fumarate
(2E)-but-2-endioat
(2E)-but-2-enedioate
1-benzofuran-2-carboxylat (ester), propan-2,2-diylbis(oxy) (INNCN)
1-benzofurane-2-carboxylate (ester), propane-2,2-diylbis(oxy) (INNCN)
furoat
furoate
furan-2(eller 3)-carboxylat
furan-2(or 3)-carboxylate
fusidat
fusidate
gamolenat (INNRG)
gamolenate (INNRG)
(6Z,9Z,12Z)-octadeca-6,9,12-trienoat (INNCN)
(6Z,9Z,12Z)-octadeca-6,9,12-trienoate (INNCN)
glucarat
glucarate
saccharat
saccharate
(2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexandioat, D-glucarat
(2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexanedioate, D-glucarate
gluceptat (INNRG)
gluceptate (INNRG)
glucoheptonat
glucoheptonate
D-glycero-D-gulo-heptonat (INNCN)
D-glycero-D-gulo-heptonate (INNCN)
gluconat
gluconate
glucosid
glucoside
3B-L-lysin,29B-L-glutaminsyre (INNCN)
3B-L-lysine,29B-L-glutamic acid (INNCN)
glutaraldehydpolymer (INNCN)
glutaraldehyde polymer (INNCN)
glycolat
glycolate
hydroxyacetat
hydroxyacetate
glyoxylat
glyoxylate
oxoacetat
oxoacetate
guld
gold
hemisuccinat (INNRG)
hemisuccinate (INNRG)
hydrogensuccinat
hydrogen succinate
hydrogenbutandioat (INNCN)
hydrogen butanedioate (INNCN)
3,3-dimethylbutanoat (ester), propan-2,2-diylbis(oxy) (INNCN)
3,3-dimethylbutanoate (ester), propan-2,2-diylbis(oxy) (INNCN)
hibenzat (INNRG)
hibenzate (INNRG)
hybenzat
hybenzate
4-(4-hydroxybenzoyl)benzoat (INNCN)
4-(4-hydroxybenzoyl)benzoate (INNCN)
hippurat
hippurate
N-benzoylglycinsalt
N-Benzoylglycine salt
hyclat (INNRG)
hyclate (INNRG)
ethanol — hydrogenchlorid — vand (0,5/1/0,5) (INNCN)
ethanol — hydrogen chloride — water (0,5/1/0,5) (INNCN)
hydrat
hydrate
hydroxybenzoat
hydroxybenzoate
2-(4-hydroxybenzoyl)ben-zoat
2-(4-hydroxybenzoyl)benzoate
o-(4-hydroxybenzoyl)benzoat
o-(4-hydroxybenzoyl)benzoate
3-hydroxynaphthalen-2-carboxylat (INNCN)
3-hydroxynaphthalene-2-carboxylate (INNCN)
iodid (INNRG)
iodide (INNRG)
jod-131
iodine-131
jernchlorid
iron chloride
isetionat (INNRG)
isetionate (INNRG)
isethionat, 2-hydroxyethansulfonat, 2-hydroxyethansulphonat
isethionate, 2-hydroxyethansulfonate, 2-hydroxyethansulphonate
2-hydroxyethan-1-sulfonat (INNCN)
2-hydroxyethane-1-sulfonate (INNCN)
isobutyrat
isobutyrate
2-methylpropanoat
2-methylpropanoate
isocaproat
isocaproate
4-methylpentanoat
4-methylpentanoate
isonicotinat
isonicotinate
pyridin-4-carboxylat
pyridine-4-carboxylate
isophthalat
isophthalate
benzen-1,3-dicarboxylat
benzene-1,3-dicarboxylate
isopropionat
isopropionate
lactat
lactate
2-hydroxypropanoat
2-hydroxypropanoate
lactobionat
lactobionate
4-O-(β-D-galactopyranosyl)-D-gluconat
4-O-(β-D-galactopyranosyl)-D-gluconate